Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Debt to Equity (2016 - 2025)

Apyx Medical (APYX) has disclosed Debt to Equity for 14 consecutive years, with $2.35 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity fell 0.62% year-over-year to $2.35, compared with a TTM value of $2.35 through Dec 2025, down 0.62%, and an annual FY2025 reading of $2.35, down 0.62% over the prior year.
  • Debt to Equity was $2.35 for Q4 2025 at Apyx Medical, down from $5.92 in the prior quarter.
  • Across five years, Debt to Equity topped out at $5.92 in Q3 2025 and bottomed at $0.24 in Q2 2023.
  • Average Debt to Equity over 3 years is $2.28, with a median of $2.3 recorded in 2024.
  • The sharpest move saw Debt to Equity surged 1027.14% in 2024, then dropped 0.62% in 2025.
  • Year by year, Debt to Equity stood at $1.23 in 2023, then skyrocketed by 91.81% to $2.36 in 2024, then dropped by 0.62% to $2.35 in 2025.
  • Business Quant data shows Debt to Equity for APYX at $2.35 in Q4 2025, $5.92 in Q3 2025, and $4.61 in Q2 2025.